Curriculum Vita of Dr. Saleh Mohaghegh Hazrati

 

NAME

 

Saleh Mohaghegh Hazrati

POSITION TITLE

Lecturer and Dean of Euromeih Training and Health Research Center, President of Iranian Biotechnology Society & Head of Puzzle Immunotherapy Committee in School of Public Health, (smhazrati@lycos.com), smhazrati@sina.tums.ac.ir

 

Address:

P.O. Box: 684-Euromieh, IR of IRAN.

 

EDUCATION/TRAINING 

 

ISTITUTION AND LOCATION

DEGREE

(if applicable)

YEAR(s)

FIELD OF STUDY

Tehran University, Tehran, IRAN

Institute of Biochemistry & Biophysic, Tehran, IRAN

School of Public Health, Tehran University, Tehran

School of Public Health, Tehran Med. Sci. University

B.Sc.

M.Sc.

MPH 

Ph.D.

1977

1983

1987

1993

Biology

Cell Biology 

Master of Public Health

Immunology

 

RESEARCH AND PROFESSIONAL EXPERIENCE:  

 

PROFESSIONAL EXPERIENCE

 

1974-1978               Laboratory Instructor, Department of Biochemistry, IRAN Pasteur Institute,

1978-1984              Pathobiologist, Department of Pathobiology of SCHOOL OF PUBLIC HEALTH, TEHERAN UNIV.,  IRAN.

1984-1993                      Assistant Lecturer, School of Public Health and Institute of Public Health Researches, Tehran Medical Science University, IR of IRAN

!991-1992               Vice president of Basic and Health Sciences Committee  of Ministry of Health, Treatment and Education

1993- Count.           Lecturer in Field of Immunology, Teaching for B.Sc., M.Sc. and Ph.D. Students.

1995- Count            Dean of Euromieh Training and Research Health Center,

1993- Count            Supervising of different M.Sc. &  Ph.D. Thesises

1999-2001                      President  of West Azerbaijan Biotechnology Society.

2002- Count.           President of Iranian Biotechnology Society,(Website: http://ibs.nrcgeb.ac.ir)

1993 – Count.          Head of Different Research Projects.

2003 –Count.           Head of Incubators Center of Biotechnology and Herbal Plants of West Azerbaijan State of IR of IRAN.

1999-2002               Head of Park of Biotechnology In West Azerbaijan State of IR of IRAN Project.

2002-Count.            Member of Herbal Medicine Committee of Minstary of Health, Treatment and Education.

 

 

Publication and Presentations

1.       Mohaghegh Hazrati S.  ,Mohtarami F. Combined non-specific Th-1 cells activator adjuvants and specific immunotherapy with auto-antigens of cancer. 3rd International Symposium on Genetic Anti-cancer Agents. Feb. 28-2 march, 2002, Amsterdam, The Netherlands . 

2.       Mohaghegh Hazrati S, et. al. Effect of Auto-antigens and Th-1 activator adjuvants on pituitary adenoma of prolactinoma. 6th International congress of endocrine disorders. Oct 5-9, 2001, Iranian J. of Endocrine and Metabolism,  O-28, pp 22. 

3.       Mohaghegh Hazrati S, et al. Review of Immunotherapy with Th-1 activator and Auto-vaccines against cancers. Seminar on Diagnostic and new methods of Cancer treatment.  June 6-8 2001, Babol University of Medical Sciences, IR of  Iran. 

4.       Mohaghegh Hazrati S,  et al. Immunotherapy of brain tumors and other cancers with immunopotent adjuvants and auto-antigens (case report). 23 April 2001, 11th International congress of Immunology, Sweden. 

5.       Mohaghegh Hazrati S & Mohtarami F. Why Th-1 activator vaccines could effective for Immunotherapy of chemical gas injured patients. The Role of  Basic Sciences on defense against  new wars. 12-13 March 2001 Tehran, University of Imam Hossein (A), IR of Iran.

6.       Mohaghegh Hazrati S, Mohtarmai F, Ghoharani R, Pakrou M, Rohi D, Mohaghegh Hazrati F.  Biotherapy of brain tumors and other cancers with immunopotent adjuvants and auto-antigens (case repot). The First North & North West Biotechnology Congress Islamic Republic of Iran. August 15-16, 2001, Urmia.

7.       Latifynia A, Mohaghegh Hazrati S, Mohebali M. Pereperation of a new formulation of leihsmanial antigen and the evaluation of its effects on cell mediated induction in BALB/c and small white laboratory mice. The 9th Iranian congress on infectious diseases and tropical medicine 14 – 18 Jan. 2001, O24, pp20. 

8.       Mohaghegh Hazrati S,  et al. The Role of GW-1, GM-1, PPD-A, PPD-B as immunopotent Adjuvants in cell Mediated Immune response against recombinant gp63 in BALB/c Mice.  April 10-13, 2000, 9th International Congress on Infectious Diseases Buenos Aires, Argentina. 

9.       Mohaghegh Hazrati S, et al. Immunotherapy of pituitary Adenoma of Prolactinoma with Adjuvants (Cases Report). 17-19 May 2000, 5th Iranian congress of Immunology and Allergy, Tehran IR of Iran. 

10.    Baban B, Soubebielle B, Sharafi J, Mohaghegh Hazrati S and Safara M. Use of Mycobacterium vaccae (SRL 172) as an immunomodulating agent in association with Murine Melanoma Model B16-F10.  Arch Razi Ins. 2000;51:4752. 

11.    Mohaghegh Hazrati S,  et al. A novel an invasive and metastatic adenocarcinoma of breast cancer (HAZ-1) in small white laboratory mice. (Complementary Report). Sept. 6-9, 1999, The Fifth Biochemistry Congress of  Uromia, IR of Iran. 

12.    Mohaghegh Hazrati S.,  et al. Biotherapy in Cancers, Asthma and Infectious  and other diseases.. Nov 1999, First Azarbidjanian Congress on Biotechnology Uromia, IR of Iran. 

13.    Mohaghegh Hazrati S, Sharafi J, Kochmeshki R & Mohtarami F. Venous Ozone Therapy in Cancer. The Fourth International Congress of Immunology & Allergry, Iran, Isfahan 13-15 May 1998. 

14.    Eskandarpour M, Elahi E, Mohaghegh Hazrati S & Moghaddam A. A study of CD44 variant isoforms in esophagus and stomach cancers. Iranian Academic Association , Second Annual Congerence Proceedings (Science and Technology in Medicine and Engineering) , 1997; 1:43-59.

15.    Eskandarpour M, Elahi E, Mohaghegh Hazrati S, Amir Moghaddam and Hasumi KI. The Study of CD44 Variant Isoforms in Different Tumors. UICC Symposium, Familial Cancer and Prevention, Molecular Epidemiology. May 14-16 1997, Kobe Japan. (Presentation). 

16.    Mohagheh Hazrati S, Rabani, Mohebeali M, Eslami MB. Evaluation of vaccination against Tetanous Toxoid within Defense Army during Iraq and Iran War.  The First Seminar of Infectious Diseases in War and Unexpected events. Bagiyatalah Medical Sience University; 21-23 Oct 1997: p21.  

17.    Mohaghegh hazrati S, Sharafi J  & Kochmeshki R. Venous Ozone Therapy in Cancer and Other Diseases 1996 (One Vol. ; 1-56). 

18.    Adam S Hay, Thor G Theander, Lars Hviid, Saleh M Hazrati, Micheal Kemp and Arsalan Kharazmi. The major surface glycoprotein (gp63) from Leishmania major and Leishmania and Leishmania donovni cleaves CD4 molecules on human T cells. J Immunol 1994;152:4542-4548.  

19.    Mohaghegh Hazrati S. The function of Viruses in Water and Waste waters. J Environmental 1988;13. 

20.    Baban, B, Mohaghegh Hazrati S, Sharafi J. Immunotherapy of Cancer with Maycobacterium vaccae. Uraemia Medical urnal 1996; 39-44.(in Persian) 

21.    Mohaghegh Hazrati Saleh & Sharafi Jamshid. Immunotherapy of Cancers. J Nabz 1994.(Persian). 

22.    Mohaghegh Hazrati S. Leishmaniasis and role of BCG on its treatment. Environmental 1984;12: 158-186. (In Persian). 

23.    ohaghegh Hazrati S. Control of Leishmaniasis through Leishmanisation. Daro-va-Darman. 1983;9:44-50 (In Persian). 

24.    Mohaghegh Hazrati S, Valizadeh M, Shojaei S. Establishing Macrophage culture for evaluation Itraconazole and Ketakonazole against leishmaniasis parasites (In vitro model) . May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation). 

25.    Mahmodzadeh A, Mohaghegh Hazrati, Sobati R & Mohtarami M. Evaluation of Leishmanization after Stopping this Method  of Control of Leishmaniasis in Islamic Rep. of Iran. XIV International Congress for Tropical medicine and Malaria, Nov. 17-22, 1996, Nagasaki, Japan.(Presentation) 

26.    Mohaghegh Hazrati S. Controversial role of BCG on treatment of cancers. First Seminar of Immunotherapy of cancer. Tehran Medical Sciences University Dec 1995. (Presentation) 

27.    Mohaghegh Hazrati S, Majidi J & Zahir Mohammed-Hassan. Effect of BCG on Leishmanization within the mice. May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation).  

28.    Mohaghegh Hazrati S. Immunoregulation of Antibody Synthesis in Sjogren's Syndrome. May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation). 

29.    Mohaghegh Hazrati S. One of  escape mechanisms of L. donovani from immune system, using surface enzymatic function. The second International Congress of Biochemistry in Iran. November 1993. (Presentation) 

30.    Mohaghegh Hazrati S. Role of (GP63) in leishmania parasites. The First Congress on Leishmaniasis in Iran. May 1991. (Presentation)

31.    Mohaghegh Hazrati S. Evaluation of Leishmanization with in Southern States of Iran. The First International Congress of Iran ( October 1988). (Presentation)

32.    Mohaghegh Hazrati S, Valizadeh M, Shojaei S. Establishing Macrophage culture for evaluation Itraconazole and Ketakonazole against leishmaniasis parasites (In vitro model) . May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation). 

33.    Mohaghegh Hazrati S. Controversial role of BCG on treatment of cancers. First Seminar of Immunotherapy of cancer. Tehran Medical Sciences University Dec 1995. (Presentation)

34.    Mohaghegh Hazrati S. Immunoregulation of Antibody Synthesis in Sjogren's Syndrome. May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation). 

35.    Mohaghegh Hazrati S, Majidi J & Zahir Mohammed-Hassan. Effect of BCG on Leishmanization within the mice. May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation).  

36.    Mohaghegh Hazrati S, Valizadeh M, Shojaei S. In vitro effect of intaconazole and keteconazol on L. major infected mouse macrophages. May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation). 

37.    Mohaghegh Hazrati S. Immunoregulation of Antibody Synthesis in Sjogren's Syndrome. May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation).

38.    Mohaghegh Hazrati S. Mohebali M, Latifinia A. Preparation of vaccine against cutaneous leishmaniasis (Phse I). May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation).  

39.    Sharafi J, Mohaghgh Hazrati S, Hasumi KI. Combined surgery, chemo, Radio- Immunotherapy of cancers. May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation). 

40.    Mohaghegh Hazrati S, Valizadeh M. NNN Modified Medium for prolonged and mass cultivationg of  Leishmania promastigotes (SPH media and HVMA 273). May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation). 

41.  Mohaghegh Hazrati S,  Pezeshki M, Khodadadi A. Evaluation of  vaccination against Tetanus within the pregnant women under PHC and Hospital Helath Cared System. May 1995,  8th International Congress of Geographic Medicine, (Infectious Diseases), Shiraz University of Medical Sciences, Shiraz, Iran. (Presentation).